Page last updated: 2024-12-08
diamsar chelate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
diamsar chelate: structure given in first source; chelating agent, coordinate with metal being chelated [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 146286 |
SCHEMBL ID | 336591 |
SCHEMBL ID | 19763310 |
SCHEMBL ID | 24427051 |
MeSH ID | M0164606 |
Synonyms (14)
Synonym |
---|
diamsar |
3,6,10,13,16,19-hexazabicyclo[6.6.6]icosane-1,8-diamine |
nh2-sar-cage |
91002-72-1 |
diamsar chelate |
1,8-diamino-3,6,10,13,16,19-hexaazabicyclo(6,6,6)eicosane |
diamine-sarcophagine |
3,6,10,13,16,19-hexaazabicyclo(6.6.6)eicosane-1,8-diamine |
3,6,10,13,16,19-hexaazabicyclo[6.6.6]eicosane-1,8-diamine |
SCHEMBL336591 |
DTXSID60238362 |
SCHEMBL19763310 |
SCHEMBL24427051 |
3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1,8-diamine |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (11)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (9.09) | 18.7374 |
1990's | 3 (27.27) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 4 (36.36) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.38
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.38) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (9.09%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (90.91%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |